Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06873139 · ClinicalTrials.gov registry record · NA
FIT4Life Text Message Program
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT06873139: Completed NA study, sponsored by Children's Mercy Hospital Kansas City.
NCT06873139 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06873139, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
FIT4Life is a text message based physical activity project that includes one baseline week and 26 weeks of intervention delivery. Study participants will be provided with fitness trackers to support their physical activity goals. The text messages are intended to motivate participants to engage in physical activity throughout the week, but do not prescribe specific exercises/workout regimens for participants to follow.
Primary Outcome
Descriptive analyses will be used to analyze the survey data and qualitative thematic analyses will be used to analyze interview data to determine participant preferences and program acceptability.
Interventions
- BEHAVIORAL text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2025-03-25 |
| Est. Completion | 2026-01-27 |
| Phase | NA |
What the finished NCT06873139 record still lists
NCT06873139 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which text messages is the first listed.
NCT06873139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06873139 about?
NCT06873139 is a clinical study titled "FIT4Life Text Message Program". FIT4Life is a text message based physical activity project that includes one baseline week and 26 weeks of intervention delivery. Study participants will be provided with fitness trackers to support their physical activity goals. The text messages are intended to motivate participants to engage in p...
What is the current status of trial NCT06873139?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2025-03-25. Estimated completion is 2026-01-27.
What interventions are being tested in trial NCT06873139?
The interventions under investigation include: text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06873139?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06873139's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI